cancer drugs

Dialectic Therapeutics cancer

The Last Word: Celanese’s Karen Chen on Partnering with Alessa Therapeutics on Cancer Drug Delivery

Dallas-based Celanese Corporation has announced a collaboration with Alessa Therapeutics for developing a new oncology drug product, by utilizing the Celanese VitalDose EVA drug delivery platform. "Our new collaboration with Alessa Therapeutics underscores our commitment to optimize therapeutics through drug delivery innovation for oncology patients,” said Karen Chen, global business strategy leader for oncology at Celanese.
Mark Cuban Cost Plus Drugs Partners with OncoPower to Help Cancer Patients Save on Medications
by | Jan 30, 2023
Dallas' Mark Cuban Cost Plus Drug Company announced a collaboration today with Houston-based OncoPower that will enable cancer patients using OncoPower to look up pricing and order less expensive medications. OncoPower offers a free app and website with a social media-style format where patients can access professionals including dietitians and behavioral therapists, as well as cancer education and meditation content, tools for treatment adherence, and clinical trial mapping.
Aakha Biologics Relocates from BioLabs Pegasus Park to Permanent North Texas HQ in Frisco
by | Jun 22, 2022
The startup—which discovers and develops immuno-oncology therapeutics for cancer patients—was an inaugural tenant of BioLabs Pegasus Park, a 37,000-square-foot coworking laboratory and office space that opened in March. Aakha had previously been working out of interim space managed by BioLabs at UT Southwestern. “With the premier facility and synergies available within Pegasus Park, we moved from concept to a solid preclinical stage company in the course of one year," Aakha Founder and CEO Hemanta Baruah said.